Avemar news

Home

New Avemar Book Release

This book discusses the mode of actions of the fermented wheat germ extract, subject of many studies in vitro on different cell lines, in vivo in animals and the human clinical trials. These studies showed that the fermented wheat germ extract had powerful anti-cancer and immunomodulatory effects.

Read more »

Avemar at Vitafoods Europe 2013

We are glad to announce, that our company will take part in the global nutraceutical event held 14-15 May at Geneva. Vitafoods Europe is the most focused event for ingredients and raw materials for the nutraceutical, functional food and drink and nutricosmetic industries.

Read more »

Avemar is gaining more and more interest in Asia

Avemar is gaining more and more interest in Asia as well as a new book on Avemar was a recently published in South Korea. It introduces the fermented wheat germ extract, newly available on the South Korean market, summarizing the background history, the mode of action and the clinical uses of Avemar.

Read more »

Avemar in Lithuania
Avemar is now available in Lithuania at UAB "Linita". Located in the city of Kaunas the Lithuanian information centre is now open for the Lithuanian customers. Patients can request product samples, get more information by phone or visit the Lithuanian information centre in person.
Read more »

Avemar in Poland
Avemar is now available in Poland through the official European Avemarshop. Further information on Avemar is now also available in Polish at the official Avemar website: www.avemar.pl or at www.avemarshop.eu. For free product samples and further information in Polish, please do not hesitate to contact the customer service at: avemar.poland@avemar.com
Read more »

FWGE – nutritional supplement or anticancer drug?
The latest publication on Avemar was published at the Nutritional Journal. According to the study, the intensified preclinical and clinical research resulting in the characterization of several mechanisms of action, provided evidence for potential versatile clinical activity.
Read more »

Avemar in the Huffington Post

David L. Katz M.D., the internationally recognized leader in integrative medicine and patient-centered care, included Avemar in his 'Super 6' list for cancer prevention. There are, of course, innumerable reports about supplements used in cancer prevention, but only a few of them is supported by a strong scientific background.

Read more »

Avemar - Promising cytotoxic activity profile

Avemar gained much attention in Europe when the latest research study was published in the Journal of Experimental Clinical Cancer Research. As recent data suggested antiproliferative, antimetastatic and immunological effects, researchers from the Department Internal Medicine, Oncology/Hematology and Hemostaseology, at University of Halle, investigated FWGE.

Read more »

Avemar at the Makassar Oncology Forum

Avemar was introduced in Indonesia at the symposium for the Association of Hematologist and Medical Oncologists, and the Association of Oncology Gynecologist organised by PT LAPI Laboratories in 2011.

Read more »

Avemar in Liverpool

Avemar was presented at the largest annual nursing conference and exhibition, the Royal College of Nursing Exhibition, in Liverpool on April 10-13th 2011.

Read more »